JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer

Tina Bagratuni; Nefeli Mavrianou; N. Gavalas; Kimon Tzannis; Calliope Arapinis; Michalis Liontos; Maria Christodoulou; Nikolaos Thomakos; Dimitrios Haidopoulos; Alexandros Rodolakis; Efstathios Kastritis; Andreas Scorilas; Meletios A Dimopoulos; Aristotle Bamias

doi:10.1016/j.ejca.2019.11.017

Related publications

Article2022

Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?

Małgorzata Gałecka, Janusz Szemraj, Kuan‐Pin Su, Angelos Halaris, Michael Maes, Aleksandra Skiba, Piotr Gałecki, Katarzyna Bliźniewska-Kowalska

Article1999

Combination Photoimmunotherapy and Cisplatin: Effects on Human Ovarian Cancer Ex Vivo

Linda Duska, Michael R Hamblin, Jaimie L. Miller, Tayyaba Hasan

Article2000

Cisplatin, epirubicin and paclitaxel combination chemotherapy in previously untreated patients with advanced epithelial ovarian cancer

Christos Papadimitriou, D. Lazaris, Alexandros Rodolakis, Christos Kiamouris, Georgios M. Gourgoulis, Eleni Galani, E Diakomanolis, S. Michalas, Meletios A Dimopoulos

Article1999

Paclitaxel, cisplatin and epirubicin (PCE) combination chemotherapy for newly diagnosed patients with advanced epithelial ovarian cancer (AEOC)

Christos Papadimitriou, Αchilles Anagnostopoulos, Zannis Voulgaris, George Vlahos, E. Kioses, T. Akrivos, Meletios A Dimopoulos

Article2012

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

August Vidal, Clara Muñoz, María-José Guillén, Jemina Moretó, Sara Puertas, María Martínez‐Iniesta, Albert Figueras, Laura Padullés, Francisco J. García-Rodríguez, Mireia Berdiel‐Acer, Miguel Ángel Pujana, Ramón Salazar, Marta Gil-Martín, Lola Martí, Jordi Ponce, David G. Mollevı́, Gabriel Capellà, Enric Condom, Francesc Viñals, Dori Huertas, Carmen Cuevas, Manel Esteller,